B Shergill

Publications (3)8.37 Total impact

• Article: Allergic contact cheilitis to garlic.

  A L Ekeowa-Anderson, B Shergill, P Goldsmith
  Contact Dermatitis 04/2007; 56(3):174-5. · 3.51 Impact Factor
• Article: Dementia associated with scleromyxoedema reversed by high-dose intravenous immunoglobulin.

  B Shergill, C H Orteu, S R McBride, M H A Rustin
  [show abstract] [hide abstract]
  ABSTRACT: Scleromyxoedema is a rare skin disease, characterized by deposition of acid mucopolysaccharides in the dermis. Although the disease primarily affects the skin, cardiovascular, renal and rheumatological manifestations have been described. In addition to these noncutaneous manifestations, about 15% of patients have central neurological symptoms such as psychosis, convulsions and encephalopathy. Successful therapy is difficult but high-dose intravenous immunoglobulin (IVIg) has been reported to be a successful treatment. We describe a patient with scleromyxoedema who presented with novel central nervous system manifestations of chronic cognitive impairment and dementia (Folstein Mini Mental State test score 8/30), which improved within a week after treatment with high-dose IVIg, with full restoration (Folstein Mini Mental State test score 27/30) at 2 months.
  British Journal of Dermatology 10/2005; 153(3):650-2. · 3.67 Impact Factor
• Article: Nail varnish is a potential allergen in nickel allergic subjects.

  B Shergill, P Goldsmith
  Clinical and Experimental Dermatology 10/2004; 29(5):545-6. · 1.20 Impact Factor